Most dupilumab use for asthma, CRSwNP categorized as persistent

Researchers characterized the use of dupilumab among a cohort of patients with asthma, chronic rhinosinusitis with nasal polyps or both as persistent in a study published in Annals of Allergy, Asthma & Immunology.
Treatment lapses were infrequent and often occurred when patients had fewer allergic or immunologic comorbidities, Kristen B. Corey, MD, clinical fellow, department of medicine, Vanderbilt University Medical Center, and colleagues wrote.
The researchers examined the pharmacy records of 81 adults (median age, 51 years; 60% women; 72% white) with a new prescription for dupilumab

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart